Steven Stoker, DO
Orthopaedic Surgery · Sandy, UTNPI 1194264374
Payments from drug & device makers
Across 78 payments — averaging $177.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pinnacle, Inc$4K
- Smith+Nephew$3K
- Medacta USA, Inc.$3K
- Stryker$2K
- Microport Orthopedics Inc$825
- Zimmer Biomet$372
- plus $613 from 5 others
What the payments were for
- Travel & lodging$6,77649%
- Food & beverage$3,48725%
- Education$3,60026%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pinnacle, Inc | 6 | $3,641 |
| Smith+Nephew | 26 | $3,416 |
| Medacta USA, Inc. | 11 | $3,126 |
| Stryker | 16 | $1,871 |
| Microport Orthopedics Inc | 4 | $825 |
| Zimmer Biomet | 7 | $372 |
| Think Surgical, Inc. | 2 | $297 |
| Johnson & Johnson | 3 | $202 |
| Baudax Bio Inc. | 1 | $80 |
| Sanofi-aventis U.S. LLC | 1 | $19 |
| Solventum Corporation | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- GMK SPHERE$2,451
- REAL INTELLIGENCE$2,308
- RI.HIP NAVIGATION$1,622
- JOURNEY$1,622
- MAKO$1,542
- Journey II$1,516
- MPO Medial Pivot Knee$747
- POLARSTEM$557
- AMISTEM$521
- INSIGNIA$352
- TRIATHLON$305
- OR3O Dual Mobility$297
- Avenir$262
- TMINI Miniature Robotic System$207
- Legion Revision$191
- LFIT$126
- BME NITINOL CONTINUOUS COMPRESSION IMPLANTS$120
- T2$104
How this compares
$13,863 in reported general payments places this provider in the 70th percentile of 221 orthopaedic surgery providers in Utah.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 12 | $6,967 |
| Oxycodone Hcl | 99 | $607 |
| Meloxicam | 128 | $565 |
| Celecoxib | 27 | $391 |
| Ondansetron OdtOndansetron | 47 | $293 |
| Cefadroxil | 56 | $289 |
| Methocarbamol | 28 | $269 |
| Cephalexin | 19 | $259 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 27 | $227 |
| Tramadol Hcl | 36 | $161 |
| Gabapentin | 19 | $136 |
| Methylprednisolone | 12 | $132 |
| Amoxicillin | 22 | $42 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Sandy
- Anthony GordonSandy$17K
- Hugh WestMurray$14.2M
- Aaron HofmannSalt Lake City$10.7M
- Armen KhachatryanWest Jordan$3.9M
- Thomas CaltonWashington Terrace$3.5M
- Jeremy GilillandSalt Lake City$3.3M
- Robert TashjianSalt Lake City$3M
- Joshua HickmanBountiful$2.7M
- Jeffrey JacksonSalt Lake City$2.3M
- Peter StevensSlc$2.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.